PetIQ Inc (PETQ)
19.94
+0.14
(+0.68%)
USD |
NASDAQ |
May 17, 16:00
19.94
0.00 (0.00%)
After-Hours: 20:00
PetIQ Debt to Equity Ratio: 1.884 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 1.884 |
December 31, 2023 | 2.018 |
September 30, 2023 | 1.886 |
June 30, 2023 | 1.921 |
March 31, 2023 | 2.036 |
December 31, 2022 | 2.153 |
September 30, 2022 | 2.123 |
June 30, 2022 | 1.733 |
March 31, 2022 | 1.859 |
December 31, 2021 | 1.807 |
September 30, 2021 | 1.711 |
June 30, 2021 | 1.744 |
March 31, 2021 | 1.811 |
December 31, 2020 | 1.866 |
Date | Value |
---|---|
September 30, 2020 | 1.369 |
June 30, 2020 | 1.121 |
March 31, 2020 | 1.123 |
December 31, 2019 | 0.9014 |
September 30, 2019 | 0.9021 |
June 30, 2019 | 0.3619 |
March 31, 2019 | 0.439 |
December 31, 2018 | 0.4276 |
September 30, 2018 | 0.6215 |
June 30, 2018 | 0.8237 |
March 31, 2018 | 1.052 |
December 31, 2017 | 0.2598 |
September 30, 2017 | 0.2855 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3619
Minimum
Jun 2019
2.153
Maximum
Dec 2022
1.616
Average
1.809
Median
Debt to Equity Ratio Benchmarks
Dynavax Technologies Corp | 0.3605 |
Pacira BioSciences Inc | 0.5832 |
Supernus Pharmaceuticals Inc | 0.00 |
Esperion Therapeutics Inc | -0.8904 |
Deciphera Pharmaceuticals Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 875.24M |
Total Liabilities (Quarterly) | 637.39M |
Shareholders Equity (Quarterly) | 235.93M |
Current Ratio | 2.418 |
Net Debt Paydown Yield | 0.28% |